MYL3/CMLC1 Antikörper
Kurzübersicht für MYL3/CMLC1 Antikörper (ABIN7116643)
Target
Alle MYL3/CMLC1 (MYL3) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- MYL3 antibody
-
Aufreinigung
- Immunogen affinity purified
-
Reinheit
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- MYL3
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB: 1:500 - 1:2000, IF: 1:50 - 1:200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze / thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C for 12 months
-
Haltbarkeit
- 12 months
-
-
- MYL3/CMLC1 (MYL3) (Myosin, Light Chain 3 (MYL3))
-
Andere Bezeichnung
- MYL3
-
Hintergrund
-
Synonyms: Myosin light chain 3|Cardiac myosin light chain 1 (CMLC1)|Myosin light chain 1, slow-twitch muscle B/ventricular isoform (MLC1SB)|Ventricular myosin alkali light chain|Ventricular myosin light chain 1 (VLCl)|Ventricular/slow twitch myosin alkali light chain (MLC-lV/sb)|MYL3
Background: MYL3 encodes myosin light chain 3, an alkali light chain also referred to in the literature as both the ventricular isoform and the slow skeletal muscle isoform. Mutations in MYL3 have been identified as a cause of mid-left ventricular chamber type hypertrophic cardiomyopathy.
-
Molekulargewicht
- 23 kDa
-
Gen-ID
- 4634
-
UniProt
- P08590
Target
-